C07C 235/40
Carboxylic acid amides, the carbon skeleton of the acid part being further
Official title: having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
C07C235/40 (Carboxylic acid amides, the carbon skeleton of the acid part being further) appears on 140 US grants and 145 published applications in this corpus.
Search patents in C07C- Granted patents
- 140
- Published applications
- 145
- Assignees
- 112
- Inventors
- 635
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 8 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 2 |
| 2002 | 10 | 5 |
| 2003 | 4 | 10 |
| 2004 | 4 | 10 |
| 2005 | 6 | 7 |
| 2006 | 6 | 5 |
| 2007 | 0 | 4 |
| 2008 | 2 | 6 |
| 2009 | 3 | 7 |
| 2010 | 5 | 6 |
| 2011 | 5 | 5 |
| 2012 | 3 | 6 |
| 2013 | 3 | 2 |
| 2014 | 4 | 2 |
| 2015 | 5 | 7 |
| 2016 | 2 | 2 |
| 2017 | 6 | 9 |
| 2018 | 4 | 4 |
| 2019 | 5 | 6 |
| 2020 | 3 | 9 |
| 2021 | 5 | 6 |
| 2022 | 2 | 2 |
| 2023 | 4 | 3 |
| 2024 | 4 | 14 |
| 2025 | 3 | 2 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mitochondrial permeability transition pore (mPTP)-opening inhibitor, novel compound exhibiting mPTP-opening inhibitory activity, and use therefor10 Feb 2026US 12,544,354 B2Riken
- Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredient27 Jan 2026US 12,534,436 B2Onecuregen Co., Ltd.
- Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof26 Aug 2025US 12,396,968 B2
- Adamantane derivatives for the treatment of filovirus infection4 Mar 2025US 12,240,857 B2Arisan Therapeutics Inc.
- Sirtuin modulating compounds and applications thereof4 Feb 2025US 12,215,069 B2Codagen Biosciences, Inc.
- Compounds useful for in vivo imaging of protein oxidation and/or cancer treatment1 Oct 2026US 2026/0295098 A1Wake Forest University Health Sciences
- Pi3k-alpha inhibitors and methods of use thereof5 Feb 2026US 2026/0035335 A1Relay Therapeutics, Inc.
- Cycloalkyl carboxylic acid derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof22 Jan 2026US 2026/0021085 A1Maze Therapeutics, Inc.
- Chemical compounds and uses thereof15 Jan 2026US 2026/0015321 A1Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Mitofusin activators having an endocyclic-bonded carbonyl group and methods for use thereof30 Oct 2025US 2025/0332124 A1
Most cited
By later US patents
- Compositions for oral delivery of active agents159US 5,650,386 AEmisphere Technologies, Inc. · 1997
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Compounds and compositions for delivering active agents125US 5,866,536 AEmisphere Technologies, Inc. · 1999
- Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents86US 7,071,355 B24 Sc AG · 2006
- Modified amino acids and compositions comprising the same for delivering active agents83US 6,071,510 AEmisphere Technologies, Inc. · 2000